All Photos(1)



Glucagon EIA Kit

for serum, plasma, culture supernatant and cell lysates


species reactivity

rat, human, mouse


kit of 96 wells (12 strips x 8 wells)


ELISA: suitable
enzyme immunoassay: suitable


sample type culture supernatant(s)
sample type cell lysate
sample type plasma
sample type serum

assay range

inter-assay cv: <15%
intra-assay cv: <10%
sensitivity: 4.77 pg/mL
standard curve range: 1–1000 pg/mL

detection method


shipped in

wet ice

storage temp.


Gene Information

human ... GCG(2641)

General description

The Glucagon Enzyme Immunoassay (EIA) Kit is an in vitro quantitative assay for detecting Glucagon peptide based on the principle of Competitive Enzyme Immunoassay.


Glucagon , synthetic peptide


For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Glucagon EIA Kit has been used in the quantification of glucagon in mice serum. It has also been used to quantitate glucagon in rat plasma.

Preparation Note

The recommended dilution for normal Serum and Plasma is 2 fold for this product.

Kit Components Also Available Separately

Product No.



Signal Word


Hazard Statements

Precautionary Statements

Hazard Classifications

Met. Corr. 1

Storage Class Code

8A - Combustible, corrosive hazardous materials



Certificate of Analysis

Certificate of Origin

High mobility group protein B1 controls liver cancer initiation through yes-associated protein-dependent aerobic glycolysis
Chen R, et al.
Hepatology, 67(5), 1823-1841 (2018)
Deletion of astrocytic BMAL1 results in metabolic imbalance and shorter lifespan in mice
Barca-Mayo O, et al.
Glia, 68(6), 1131-1147 (2020)
Firdevs Mor et al.
Toxins, 9(4) (2017-04-20)
In this study, the diabetogenic effects of long term Ochratoxin A (OTA) administration in rats were investigated, and its role in the etiology of diabetes mellitus (DM) was examined utilizing 42 female Wistar rats for these purposes. The rats were
Rachel J Perry et al.
The Journal of clinical investigation, 127(2), 657-669 (2017-01-24)
The mechanism by which leptin reverses diabetic ketoacidosis (DKA) is unknown. We examined the acute insulin-independent effects of leptin replacement therapy in a streptozotocin-induced rat model of DKA. Leptin infusion reduced rates of lipolysis, hepatic glucose production (HGP), and hepatic
Diabetogenic Effects of Ochratoxin A in Female Rats
Mor F, et al.
Toxins, 9(4), 144-144 (2017)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service